Colorectal cancer: the role of PET/CT in recurrence: Wednesday 5 October 2005, 14:00–16:00

Many imaging modalities and scanning techniques, such as contrast enhanced CT, MRI and FDG-PET, are available for assessment of recurrent colorectal carcinoma. In addition, integrated PET/CT is becoming increasingly available. Intuitively, a synergistic combination of scanning characteristics sounds...

Descripción completa

Detalles Bibliográficos
Autores principales: Vogel, Wouter V, Wiering, Bastiaan, Corstens, Frans H M, Ruers, Theo J M, Oyen, Wim J G
Formato: Texto
Lenguaje:English
Publicado: e-MED 2005
Materias:
Multidisciplinary Symposium: Colorectal Cancer
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1665301/
https://www.ncbi.nlm.nih.gov/pubmed/16361130
http://dx.doi.org/10.1102/1470-7330.2005.0034
Descripción
Sumario:Many imaging modalities and scanning techniques, such as contrast enhanced CT, MRI and FDG-PET, are available for assessment of recurrent colorectal carcinoma. In addition, integrated PET/CT is becoming increasingly available. Intuitively, a synergistic combination of scanning characteristics sounds promising. However, the exact clinical value has not yet been fully established. The role of PET/CT image fusion must be weighed carefully against other available modalities. In this review we evaluate the potential of combined PET/CT in recurrent colorectal carcinoma. When available, PET/CT currently appears the diagnostic tool of choice. In the near future, combined PET/MRI may further enhance the diagnostic algorithm.

Ejemplares similares